Thanks to modern treatments, HIV, though incurable, is far from the death sentence it once was. But it is still a life sentence, coming with the high cost, both personal and economic, of chronic disease, making avoiding infection in the first place a major goal for public health agencies. To that end, after numerous trials, the FDA has now approved Truvada, a combination drug that is already being used to treat HIV, as a preventative.
What’s the News: Researchers have embarked upon an experiment that, if not for the tragic circumstances of the African AIDS epidemic, might be familiar to many parents: paying kids to follow the rules. South African schoolchildren 13 years and older in the study could earn up to $400 if they manage to stay HIV-free for 24 months. In South Africa, which has the most HIV/AIDS-infected people of any country in the world, more than 17 percent of the population has HIV, with girls at especially high risk.